Multi-marker biomarker panel, adverse cardiovascular and kidney outcomes, and response to canagliflozin in the CANVAS Program
29 June 2021 (14:00 - 15:00)
Organised by:
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
8 More presentations in this session
Doctor D. Salvador (Bern, CH)
Mr S. Mueller Stegner (Munich, DE)
Miss E. Feyen (Antwerp, BE)
Doctor J. Heemelaar (Leiderdorp, NL)
Access the full session
The Event
Heart Failure 2021
29 June 2021
14:00 CET
